SCHEMBL26102469

SCHEMBL26102469

O=C1NC[C@@H](CI)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15757682 1.00
SCHEMBL14731300 0.84
SCHEMBL4578719 0.84
SCHEMBL12564801 0.81 ALDH1A1 (0.50)
SCHEMBL7356952 0.77
SCHEMBL87711 0.77
SCHEMBL523957 0.77
SCHEMBL2281276 0.77
SCHEMBL3954454 0.77
SCHEMBL523804 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4423070-A1 BENZO[H]QUINAZOLINE-4-AMINE DERIVATIVES FOR THE TREATMENT OF CANCER Redona Therapeutics, Inc. (US) 2024-09-04 EP disclosed
CN-118541354-A Benzo [ h ] quinazolin-4-amine derivatives for the treatment of cancer 雷多纳治疗公司 2024-08-23 CN disclosed
WO-2023196629-A1 BENZO[H]QUINAZOLINE-4-AMINE DERIVATIVES FOR THE TREATMENT OF CANCER Redona Therapeutics, Inc. (US) 2023-10-12 WO disclosed
WO-2023072913-A1 BENZO[H]QUINAZOLINE-4-AMINE DERIVATIVES FOR THE TREATMENT OF CANCER TWENTYEIGHT-SEVEN, INC. (US) 2023-05-04 WO disclosed